Evolent Health, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US30050B1017
USD
4.01
0.1 (2.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Evolent Health, Inc. stock-summary
stock-summary
Evolent Health, Inc.
Miscellaneous
Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.
Company Coordinates stock-summary
Company Details
800 N Glebe Rd Ste 500 , ARLINGTON VA : 22203-2151
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 88 Schemes (60.15%)

Foreign Institutions

Held by 140 Foreign Institutions (17.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Frank Williams
Executive Chairman of the Board, Co-Founder
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Ms. Cheryl Scott
Lead Independent Director
Mr. David Farner
Director
Ms. Diane Holder
Director
Ms. Kim Keck
Director
Mr. Craig Barbarosh
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
444 Million
(Quarterly Results - Jun 2025)
Net Profit:
-20 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 1,151 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.00

stock-summary
Return on Equity

-10.28%

stock-summary
Price to Book

1.28